Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:clinical_trial
|
| gptkbp:ageRange |
18 years and older
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:completedIn |
August 2020
|
| gptkbp:conditionStudied |
gptkb:COVID-19
|
| gptkbp:enrollment |
630
|
| https://www.w3.org/2000/01/rdf-schema#label |
NCT04374877
|
| gptkbp:intervention |
gptkb:Azithromycin
Hydroxychloroquine |
| gptkbp:location |
gptkb:United_States
|
| gptkbp:officialName |
Hydroxychloroquine and Azithromycin for the Treatment of Hospitalized Patients With COVID-19
|
| gptkbp:primaryCompletionDate |
August 2020
|
| gptkbp:primaryOutcomeMeasure |
Clinical status at day 14
|
| gptkbp:principalInvestigator |
Christine Johnston
|
| gptkbp:recognizedBy |
gptkb:NCT04374877
|
| gptkbp:secondaryOutcomeMeasure |
All-cause mortality
Duration of hospitalization |
| gptkbp:sponsor |
gptkb:University_of_Washington
|
| gptkbp:startDate |
April 2020
|
| gptkbp:status |
Completed
|
| gptkbp:studyType |
Interventional
Parallel Assignment Randomized Open Label |
| gptkbp:bfsParent |
gptkb:SRF388
|
| gptkbp:bfsLayer |
8
|